Literature DB >> 11861868

Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons.

Ralph S Baric1, Boyd Yount, Lisa Lindesmith, Patrick R Harrington, Shermalyn R Greene, Fan-Chen Tseng, Nancy Davis, Robert E Johnston, David G Klapper, Christine L Moe.   

Abstract

The Norwalk virus (NV) capsid protein was expressed using Venezuelan equine encephalitis virus replicon particles (VRP-NV1). VRP-NV1 infection resulted in large numbers of recombinant NV-like particles that were primarily cell associated and were indistinguishable from NV particles produced from baculoviruses. Mutations located in the N-terminal and P1 domains of the NV capsid protein ablated capsid self-assembly in mammalian cells.

Entities:  

Mesh:

Year:  2002        PMID: 11861868      PMCID: PMC135954          DOI: 10.1128/jvi.76.6.3023-3030.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  A method to detect low levels of enteric viruses in contaminated oysters.

Authors:  Y C Shieh; K R Calci; R S Baric
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

2.  Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors:  N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Expression and self-assembly of empty virus-like particles of hepatitis E virus.

Authors:  T C Li; Y Yamakawa; K Suzuki; M Tatsumi; M A Razak; T Uchida; N Takeda; T Miyamura
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells.

Authors:  L J White; M E Hardy; M K Estes
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Authors:  G H MacDonald; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Expression and self-assembly of recombinant capsid protein from the antigenically distinct Hawaii human calicivirus.

Authors:  K Y Green; A Z Kapikian; J Valdesuso; S Sosnovtsev; J J Treanor; J F Lew
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

7.  Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.

Authors:  I J Caley; M R Betts; D M Irlbeck; N L Davis; R Swanstrom; J A Frelinger; R E Johnston
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.

Authors:  P C Charles; K W Brown; N L Davis; M K Hart; R E Johnston
Journal:  Virology       Date:  1997-02-17       Impact factor: 3.616

9.  X-ray crystallographic structure of the Norwalk virus capsid.

Authors:  B V Prasad; M E Hardy; T Dokland; J Bella; M G Rossmann; M K Estes
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

10.  A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

Authors:  N L Davis; K W Brown; R E Johnston
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more
  43 in total

1.  Snow Mountain virus genome sequence and virus-like particle assembly.

Authors:  Vance P Lochridge; Michele E Hardy
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

2.  Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples.

Authors:  Jonathan A Burton-MacLeod; Erin M Kane; Rachel S Beard; Leslie A Hadley; Roger I Glass; Tamie Ando
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.

Authors:  Jesica Swanstrom; Lisa C Lindesmith; Eric F Donaldson; Boyd Yount; Ralph S Baric
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

4.  Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.

Authors:  Amy C Sims; Ralph S Baric; Boyd Yount; Susan E Burkett; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Model systems for the study of human norovirus Biology.

Authors:  S Vashist; D Bailey; A Putics; I Goodfellow
Journal:  Future Virol       Date:  2009-07       Impact factor: 1.831

6.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition.

Authors:  Pengwei Huang; Ardythe L Morrow; Xi Jiang
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

8.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Authors:  Jennifer L Cannon; Lisa C Lindesmith; Eric F Donaldson; Lauryn Saxe; Ralph S Baric; Jan Vinjé
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding.

Authors:  David J Allen; Rob Noad; Dhan Samuel; Jim J Gray; Polly Roy; Miren Iturriza-Gómara
Journal:  Virol J       Date:  2009-09-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.